January 2025 in “JCEM Case Reports” Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.
January 2025 in “Lusophone University Repository” Nanotechnology can help fight skin aging, but safety concerns limit its use.
October 2024 in “International Journal of Pharmaceutics” The finasteride patch effectively treats hair loss by enhancing skin absorption.
July 2024 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” PRP shows promise in improving skin health and rejuvenation, but more research is needed.
January 2024 in “Editora In Vivo eBooks” H5N1 avian flu poses risks to birds and humans, requiring strict biosecurity measures.
June 2023 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” Minoxidil, finasteride, and PRP are the most effective and accessible treatments for male pattern hair loss.
March 2023 in “Brazilian Journal of Health Review” The combination tablet of finasteride and doxazosin works the same as taking each drug separately.
Phototherapy with red or blue light can safely improve hair growth and scalp health in androgenetic alopecia.
December 2022 in “Zenodo (CERN European Organization for Nuclear Research)” Topical finasteride effectively treats hair loss and acne with fewer side effects than oral forms.
July 2022 in “Conjeturas” Androgens play a key role in causing alopecia by changing the hair growth cycle.
September 2020 in “Hair transplant forum international” O'Tar T. Norwood was a key figure in creating a system to classify male baldness and founding hair restoration societies.
March 2020 in “Revista Eletrônica da Faculdade de Ceres” Latanoprost's effectiveness for hair growth is not confirmed but shows promise, needing more research.
January 2018 in “Surgical and Cosmetic Dermatology” Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.
January 2011 in “Dermatologic Clinics” Emotional neglect in parent-child relationships may warrant compensation, but not all cases qualify.
Many women in Recife lack understanding of the climacteric period, needing better education and care.
September 2005 in “Revue de Stomatologie et de Chirurgie Maxillo-faciale” January 2005 in “Dialnet (Universidad de la Rioja)” Post-SSRI sexual dysfunction syndrome was formally recognized in 2006, impacting clinical practice and research.
November 1968 in “Journal of the American Pharmaceutical Association” 79 citations
,
October 2003 in “PubMed” Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.
77 citations
,
January 1980 in “Carcinogenesis” TPA is about 50 times more effective at promoting tumors than MZ.
42 citations
,
June 2019 in “Aging” 3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.
23 citations
,
June 2010 in “Journal of Investigative Dermatology” A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.
13 citations
,
March 2020 in “Frontiers in cell and developmental biology” A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.
4 citations
,
January 2001 in “Archives of Biochemistry and Biophysics” Activated ras can protect kidney cells from a certain substance that causes cell death.
3 citations
,
November 2011 in “European Journal of Dermatology” 4-O-methylhonokiol from Magnolia officinalis significantly promotes hair growth.
2 citations
,
June 2022 in “Journal of Applied Pharmaceutical Science” 4-O-Methylhonokiol from Magnolia shows promise for hair growth, cancer, diabetes, and more, but needs better absorption.
October 2025 in “Actualización en Medicina de Familia” New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.
April 2025 in “Antioxidants” Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.